New Delhi, Nov 23 (PTI) Drug delivery solution provider ZIM Laboratories Ltd on Wednesday said it is planning to get listed on the National Stock Exchange of India (NSE) on November 25.

ZIM Laboratories, already listed on the BSE since June 2018, will now extend its listing to the NSE, the company said in a statement.

Also Read | Paytm To Remain Unaffected by NPCI's UPI Market Cap Move, Say Experts.

As of date, the company said, it has provided over 85 per cent return to its investors from the listing price.

According to the September 2022 shareholding pattern available with the BSE, the company's promoters own a 33.26 per cent stake in the firm, of which, Dr Anwar Daud, Chairman and Managing Director, holds a 27.37 per cent stake and Mathew Cyriac, Executive Chairman, Florintree Advisors, as an investor owns 21.86 per cent.

Also Read | Gujarat Assembly Elections 2022: From Hardik Patel to Jignesh Mevani and Parshottam Solanki, List of Key Candidates and Constituencies Going to Polls.

ZIM Laboratories is a pharmaceutical company, focused on providing innovative drug delivery solutions that provide patient convenience and adherence to drug treatment.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)